The fundamental role of endothelial cells in hantavirus pathogenesis

Article English OPEN
Jussi eHepojoki; Antti eVaheri; Tomas eStrandin;
(2014)
  • Publisher: Frontiers Media S.A.
  • Journal: Frontiers in Microbiology, volume 5 (issn: 1664-302X, eissn: 1664-302X)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.3389/fmicb.2014.00727/full, doi: 10.3389/fmicb.2014.00727, pmc: PMC4273638
  • Subject: NECROSIS-FACTOR-ALPHA | Perspective Article | PUUMALA-HANTAVIRUS | Microbiology | RECEPTOR ANTAGONIST ICATIBANT | QR1-502 | RENAL SYNDROME | endothelial dysfunction | HCPS | HFRS | IMMUNE-RESPONSE | TNF-ALPHA | NEPHROPATHIA-EPIDEMICA | 3111 Biomedicine | hantavirus | VIRUS NUCLEOCAPSID PROTEIN | bunyavirus | HEMORRHAGIC-FEVER | PULMONARY SYNDROME
    mesheuropmc: viruses | respiratory tract diseases | virus diseases | animal diseases

Hantavirus, a genus of rodent- and insectivore-borne viruses in the family Bunyaviridae, is a group of emerging zoonotic pathogens. Hantaviruses cause hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome in man, often with severe consequences. V... View more
  • References (88)
    88 references, page 1 of 9

    Abel Borges A. Figueiredo L. T. (2008). Mechanisms of shock in hantavirus pulmonary syndrome. Curr. Opin. Infect. Dis. 21 293–297. 10.1097/QCO.0b013e3282f88b6f

    Antonen J. Leppanen I. Tenhunen J. Arvola P. Makela S. Vaheri A. (2013). A severe case of puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Scand. J. Infect. Dis. 45 494–496. 10.3109/00365548.2012.755268

    Borges A. A. Donadi E. A. Campos G. M. Moreli M. L. de Sousa R. L. Saggioro F. P. (2010). Association of -308G/A polymorphism in the tumor necrosis factor-alpha gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the ribeirao preto region, Brazil. Arch. Virol. 155 971–975. 10.1007/s00705-010-0655-7

    Buranda T. Wu Y. Perez D. Jett S. D. BonduHawkins V. Ye C. (2010). Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: toward the development of high-throughput screening flow cytometry assays. Anal. Biochem. 402 151–160. 10.1016/j.ab.2010.03.016

    Cosgriff T. M. (1991). Mechanisms of disease in hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev. Infect. Dis. 13 97–107. 10.1093/clinids/13.1.97

    Duchin J. S. Koster F. T. Peters C. J. Simpson G. L. Tempest B. Zaki S. R. (1994). Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N. Engl. J. Med. 330 949–955. 10.1056/NEJM199404073301401

    Easterbrook J. D. Klein S. L. (2008). Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog. 4:e1000172. 10.1371/journal.ppat.1000172

    Eklund L. Saharinen P. (2013). Angiopoietin signaling in the vasculature. Exp. Cell Res. 319 1271–1280. 10.1016/j.yexcr.2013.03.011

    Engelmann B. Massberg S. (2013). Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13 34–45. 10.1038/nri3345

    Gavrilovskaya I. Gorbunova E. Koster F. Mackow E. (2012). Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. Adv. Virol. 2012:674360. 10.1155/2012/674360

  • Related Research Results (2)
  • Metrics
Share - Bookmark